Literature DB >> 16522661

Racial disparities in the prevalence of cardiovascular disease among incident end-stage renal disease patients.

Nataliya Volkova1, William McClellan, J Michael Soucie, Anton Schoolwerth.   

Abstract

BACKGROUND: Prevalence of coronary heart disease (CHD) and heart failure (HF) is higher among blacks as compared with whites in general population. This study describes unexpected racial differences in the prevalence of CHD and HF among incident dialysis patients, with whites being at a disadvantage.
METHODS: Data were obtained from Centers for Medicare and Medicaid Services (CMS) 2728 form for incident dialysis patients in Georgia, North Carolina and South Carolina in 1995-2003. The CHD and HF prevalence between races were compared using adjusted odds ratios (ORs). The potential for case ascertainment bias was assessed.
RESULTS: Compared with whites (n = 23 951), black patients (n = 32 642) had lower prevalence of CHD (15.7 vs 31.2%) and HF (28.1 vs 34.1%). After controlling for age, gender, diabetes, hypertension and smoking, the association of race with CHD varied by gender and diabetes status: OR ranged from 0.36 (0.34-0.39) for non-diabetic males to 0.57 (0.53-0.61) for diabetic females. Racial differences were not fully explained by case ascertainment bias. The race-HF association varied by age, gender and diabetes: among patients aged <55, blacks tended to have higher prevalence than whites (OR ranged from 0.99 (0.90-1.09) for diabetic males to 1.25 (1.13-1.39) for non-diabetic females), but among those aged above 55, blacks were less likely to HF (OR ranged from 0.62 (0.58-0.67) for diabetic males to 0.79 (0.73-0.85) for non-diabetic females).
CONCLUSIONS: Substantial racial disparities exist in CHD/HF prevalence among incident dialysis patients that persist after controlling for confounders and cannot be fully explained by disease misclassification.

Entities:  

Mesh:

Year:  2006        PMID: 16522661     DOI: 10.1093/ndt/gfl078

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  19 in total

1.  Factors influencing enrollment of African Americans in the Look AHEAD trial.

Authors:  David L Mount; Cralen Davis; Betty Kennedy; Susan Raatz; Kathy Dotson; Tiffany L Gary-Webb; Sheikilya Thomas; Karen C Johnson; Mark A Espeland
Journal:  Clin Trials       Date:  2011-11-07       Impact factor: 2.486

2.  Does the relationship between natriuretic hormones and diastolic function differ by race?

Authors:  Gaston K Kapuku; Harry C Davis; Patrick Thomas; James Januzzi; Gregory A Harshfield
Journal:  Am J Med Sci       Date:  2012-08       Impact factor: 2.378

3.  Possible effects of the new Medicare reimbursement policy on African Americans with ESRD.

Authors:  Areef Ishani; Haifeng Guo; Thomas J Arneson; David T Gilbertson; Lih-Wen Mau; Suying Li; Stephan Dunning; Allan J Collins
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

4.  Impact of race on cumulative exposure to antihypertensive medications in dialysis.

Authors:  James B Wetmore; Jonathan D Mahnken; Sally K Rigler; Edward F Ellerbeck; Purna Mukhopadhyay; Qingjiang Hou; Theresa I Shireman
Journal:  Am J Hypertens       Date:  2012-12-28       Impact factor: 2.689

5.  The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients.

Authors:  James B Wetmore; Jonathan D Mahnken; Sally K Rigler; Edward F Ellerbeck; Purna Mukhopadhyay; John A Spertus; Qingjiang Hou; Theresa I Shireman
Journal:  Kidney Int       Date:  2011-12-21       Impact factor: 10.612

6.  Thiazolidinediones and cardiovascular events in high-risk patients with type-2 diabetes mellitus: a comparison with other oral antidiabetic agents.

Authors:  Fadia T Shaya; Zhiqiang Lu; Kyongsei Sohn; Matthew R Weir
Journal:  P T       Date:  2009-09

7.  Racial and ethnic differences in the association of body mass index and survival in maintenance hemodialysis patients.

Authors:  Joni Ricks; Miklos Z Molnar; Csaba P Kovesdy; Joel D Kopple; Keith C Norris; Rajnish Mehrotra; Allen R Nissenson; Onyebuchi A Arah; Sander Greenland; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

8.  Relationship between calcium channel blocker class and mortality in dialysis.

Authors:  James B Wetmore; Jonathan D Mahnken; Milind A Phadnis; Edward F Ellerbeck; Theresa I Shireman
Journal:  Pharmacoepidemiol Drug Saf       Date:  2015-09-15       Impact factor: 2.890

9.  Angiotensin-related genetic determinants of cardiovascular disease in patients undergoing hemodialysis.

Authors:  Sharon M Moe; Jin Long; Tae-Hwi Linus Schwantes-An; Brian S Decker; Leah Wetherill; Howard J Edenberg; Xiaoling Xuei; Matteo Vatta; Tatiana M Foroud; Glenn M Chertow
Journal:  Nephrol Dial Transplant       Date:  2019-11-01       Impact factor: 5.992

10.  Survival of patients from South Asian and Black populations starting renal replacement therapy in England and Wales.

Authors:  Paul Roderick; Catherine Byrne; Anna Casula; Retha Steenkamp; David Ansell; Richard Burden; Dorothea Nitsch; Terry Feest
Journal:  Nephrol Dial Transplant       Date:  2009-07-21       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.